AAAAAA

   
Results: 1-7 |
Results: 7
RETINOPATHY AND OPTIC NEUROPATHY AFTER TRANSPLANTATION - REPLY
Authors: KHAWLY JA JAFFE GJ RUBIN P PETROS W
Citation: Ja. Khawly et al., RETINOPATHY AND OPTIC NEUROPATHY AFTER TRANSPLANTATION - REPLY, Ophthalmology, 104(2), 1997, pp. 170-171
RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) IN PATIENTS WITH BREAST-CANCERFOLLOWING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL (AHPC) SUPPORT
Authors: HUSSEIN A VREDENBURGH J ELKORDY M RUBIN P FISHER D CANALES R PETROS W GILBERT C PERET N DYKSTRA K LOEWY J KAYE JA PETERS WP
Citation: A. Hussein et al., RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) IN PATIENTS WITH BREAST-CANCERFOLLOWING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL (AHPC) SUPPORT, Experimental hematology, 24(9), 1996, pp. 634-634
THROMBOTIC MICROANGIOPATHY AS A COMPLICATION OF HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER
Authors: FISHER DC SHERRILL GB HUSSEIN A RUBIN P VREDENBURGH JJ ELKORDY M ROSS M PETROS W PETERS WP
Citation: Dc. Fisher et al., THROMBOTIC MICROANGIOPATHY AS A COMPLICATION OF HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER, Bone marrow transplantation, 18(1), 1996, pp. 193-198
RETINOPATHY AND OPTIC NEUROPATHY IN BONE-MARROW TRANSPLANTATION FOR BREAST-CANCER
Authors: KHAWLY JA RUBIN P PETROS W PETERS WP JAFFE GJ
Citation: Ja. Khawly et al., RETINOPATHY AND OPTIC NEUROPATHY IN BONE-MARROW TRANSPLANTATION FOR BREAST-CANCER, Ophthalmology, 103(1), 1996, pp. 87-95
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR A PATIENT WITH ACUTE-LEUKEMIA AND END-STAGE RENAL-DISEASE (ESRD) - CLINICAL COURSE AND PHARMACOKINETICS OF HIGH-DOSE CYCLOPHOSPHAMIDE (CTX)
Authors: PERRY J FLEMING R BLEYER A PETROS W ROCCO M RADFORD J POWELL B HURD D
Citation: J. Perry et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR A PATIENT WITH ACUTE-LEUKEMIA AND END-STAGE RENAL-DISEASE (ESRD) - CLINICAL COURSE AND PHARMACOKINETICS OF HIGH-DOSE CYCLOPHOSPHAMIDE (CTX), Blood, 86(10), 1995, pp. 3831-3831
HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER
Authors: PETERS WP ROSS M VREDENBURGH JJ MEISENBERG B MARKS LB WINER E KURTZBERG J BAST RC JONES R SHPALL E WU K ROSNER G GILBERT C MATHIAS B CONIGLIO D PETROS W HENDERSON IC NORTON L WEISS RB BUDMAN D HURD D
Citation: Wp. Peters et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1132-1143
EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) EXPRESSED IN CHINESE-HAMSTER OVARY CELLS (CHO-GM), ESCHERICHIA-COLI (E-COLI-GM) OR YEAST (YEAST-GM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY
Authors: HUSSEIN A ROSS M VREDENBURGH J MEISENBERG B GILBERT C PETROS W CONIGLIO D KURTZBERG J PETERS WP
Citation: A. Hussein et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) EXPRESSED IN CHINESE-HAMSTER OVARY CELLS (CHO-GM), ESCHERICHIA-COLI (E-COLI-GM) OR YEAST (YEAST-GM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY, Blood, 82(10), 1993, pp. 10000293-10000293
Risultati: 1-7 |